Adodo Yao Sadji
Overview
Explore the profile of Adodo Yao Sadji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Itsko M, Topaz N, Ousmane-Traore S, Popoola M, Ouedraogo R, Gamougam K, et al.
J Infect Dis
. 2022 Mar;
226(4):729-737.
PMID: 35325163
Rollout of meningococcal serogroup A conjugate vaccine in Africa started in 2010, aiming to eliminate meningitis outbreaks, in meningitis belt countries. Since then, studies have been conducted, primarily using isolates,...
2.
Feagins A, Sadji A, Topaz N, Itsko M, Halatoko J, Dzoka A, et al.
Microbiol Spectr
. 2022 Mar;
10(2):e0192321.
PMID: 35234504
Togo has reported seasonal meningitis outbreaks caused by non-Neisseria meningitidis serogroup A (NmA) pathogens since the introduction of meningococcal serogroup A conjugate vaccine (MACV, MenAfriVac) in 2014. From 2016 to...
3.
Itsko M, Retchless A, Joseph S, Norris Turner A, Bazan J, Sadji A, et al.
J Clin Microbiol
. 2020 Sep;
58(12).
PMID: 32938738
is a leading cause of bacterial meningitis and sepsis worldwide and an occasional cause of meningococcal urethritis. When isolates are unavailable for surveillance or outbreak investigations, molecular characterization of pathogens...
4.
Mbaeyi S, Lingani C, Diallo A, Bicaba B, Ouedraogo-Traore R, Acyl M, et al.
J Infect Dis
. 2019 Nov;
220(220 Suppl 4):S155-S164.
PMID: 31671451
Background: The MenAfriNet consortium was established in 2014 to support implementation of case-based meningitis surveillance in 5 countries in the meningitis belt of sub-Saharan Africa: Burkina Faso, Chad, Mali, Niger,...
5.
Soeters H, Diallo A, Bicaba B, Kadade G, Dembele A, Acyl M, et al.
J Infect Dis
. 2019 Nov;
220(220 Suppl 4):S165-S174.
PMID: 31671441
Background: The MenAfriNet Consortium supports strategic implementation of case-based meningitis surveillance in key high-risk countries of the African meningitis belt: Burkina Faso, Chad, Mali, Niger, and Togo. We describe bacterial...
6.
Mounkoro D, Nikiema C, Maman I, Sakande S, Bozio C, Tall H, et al.
J Infect Dis
. 2019 Nov;
220(220 Suppl 4):S216-S224.
PMID: 31671438
Background: During 2014, 4 regions in Togo within the African meningitis belt implemented vaccination campaigns with meningococcal serogroup A conjugate vaccine (MACV). From January to July 2016, Togo experienced its...
7.
Salah F, Soubeiga S, Ouattara A, Sadji A, Metuor-Dabire A, Obiri-Yeboah D, et al.
Antimicrob Resist Infect Control
. 2019 Jun;
8:104.
PMID: 31244995
Background: genes are known to confer a low-level resistance to fluoroquinolone in . They are often found on the same resistance plasmids as extended spectrum β-lactamase (ESBL) and constitute the...
8.
Moore S, Dongdem A, Opare D, Cottavoz P, Fookes M, Sadji A, et al.
PLoS Negl Trop Dis
. 2018 Apr;
12(4):e0006379.
PMID: 29630632
Background: The countries of West Africa are largely portrayed as cholera endemic, although the dynamics of outbreaks in this region of Africa remain largely unclear. Methodology/principal Findings: To understand the...
9.
Moore S, Miwanda B, Sadji A, Thefenne H, Jeddi F, Rebaudet S, et al.
PLoS Negl Trop Dis
. 2015 Jun;
9(6):e0003817.
PMID: 26110870
Background: Since cholera appeared in Africa during the 1970s, cases have been reported on the continent every year. In Sub-Saharan Africa, cholera outbreaks primarily cluster at certain hotspots including the...